SCHEMBL5400873

SCHEMBL5400873

O=C1CSCCN1.O=S1(=O)CCCCC1

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
OR51E2 Q9H255 1/20 0.31
FKBP5 Q13451 1/20 0.30
CRBN Q96SW2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL89026 0.82
SCHEMBL16212435 0.82
Hydrochloric Acid SCHEMBL1524100 0.80
SCHEMBL11556195 0.78 CRBN (0.35) OR51E2FKBP5CRBN
SCHEMBL10082272 0.74 OR51E2 (0.42) OR51E2FKBP5CRBN
SCHEMBL10083633 0.74 OR51E2 (0.42) OR51E2FKBP5CRBN
SCHEMBL1269125 0.73
SCHEMBL14501416 0.72 CRBN (0.37) OR51E2FKBP5CRBN
Hydrochloric Acid SCHEMBL31232406 0.71
SCHEMBL4071271 0.71 OR51E2 (0.34) OR51E2FKBP5CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2007503453-A 2007-02-22 JP claimed
EP-1625112-A1 NOVEL COMPOUNDS FOR TREATMENT OF OBESITY NOVO NORDISK A/S (DK) 2006-02-15 EP claimed
WO-2004101505-A1 NOVEL COMPOUNDS FOR TREATMENT OF OBESITY NOVO NORDISK A/S (DK) 2004-11-25 WO claimed